BioAdaptives (OTC:BDPT) Research Outlook from Ludlow Research
(NEW YORK)–Ludlow Research alerted premium subscribers last week to monitor BioAdaptives, Inc. (OTCID: BDPT) as pivotal balance sheet milestones began taking shape. Validating that early call, the company officially announced the commercial launch and pre-order availability for XcellaraHeart™, the flagship product in its novel Xcellara™ cellular wellness suite. XcellaraHeart™ introduces a dual-mechanism “Supply & Direction”…
